Edgewise Therapeutics, Inc. (EWTX) Reports In-Line Q1 EPS

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q1 EPS of ($0.36), in-line with the analyst estimate of ($0.36).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM
• Edgewise Therapeutics (EWTX) PT Raised to $59; RBC Capital: 'We would be buyers on weakness'